情報ありがとうございます。一応拝読しましたが、ご提示の文章の後にThese results indicate that incorporating HAL training does not influence the beneficial outcome seen in these younger patients who received evidence-based, CGT in a specialized neurorehabilitation setting due to severely limited walking ability after stroke.上述特定条件の場合、差異が出ないということですね。また、結論のところ、This study found no difference between groups for any outcomes after the intervention or at 6 months post stroke, despite the extra resources required for the HAL training. In these younger patients with hemiparesis and severe limitations in walking in the subacute stage after stroke independence in walking at 6 months was not related to group allocation but to a younger age. The results should be interpreted with caution considering that the sample size was small, and that between-group differences were less and variance greater than expected. The findings suggest that further explorations of who in the heterogeneous stroke population will benefit the most from EAGT should be addressed in future studies. 今回の研究にはサンプルが少ないなど問題が分かり、引き続き調査するとのことです。別にHAL治療がダメと言っているわけではないと思います。
>>1036
情報ありがとうございます。一応拝読しましたが、ご提示の文章の後にThese results indicate that incorporating HAL training does not influence the beneficial outcome seen in these younger patients who received evidence-based, CGT in a specialized neurorehabilitation setting due to severely limited walking ability after stroke.上述特定条件の場合、差異が出ないということですね。また、結論のところ、This study found no difference between groups for any outcomes after the intervention or at 6 months post stroke, despite the extra resources required for the HAL training. In these younger patients with hemiparesis and severe limitations in walking in the subacute stage after stroke independence in walking at 6 months was not related to group allocation but to a younger age. The results should be interpreted with caution considering that the sample size was small, and that between-group differences were less and variance greater than expected. The findings suggest that further explorations of who in the heterogeneous stroke population will benefit the most from EAGT should be addressed in future studies. 今回の研究にはサンプルが少ないなど問題が分かり、引き続き調査するとのことです。別にHAL治療がダメと言っているわけではないと思います。